Skip to content
SkimSkim home

Public sector tenders

In deliveryUnited KingdomServicesAdd to pipeline

Research and Develop Tax Credit Project

Awarded to Ernst & Young LLC

CELL THERAPY CATAPULT LIMITED(buyer)

Published
Published 8 September 2025
Deadline
Closed 6 October 2025

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

Cell Therapy Catapult Limited has awarded a contract to Ernst & Young LLC for research and development of a tax credit project, completed as of November 2025. The scope includes preparing and submitting Research and Development Tax Credit claims under HMRC guidelines, with submissions required at least one calendar month before HMRC deadlines, to support innovation and investment in qualifying R&D activities through optimised and defensible claims.

Contracting authority

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Key details

Country
United Kingdom
Status
In delivery
Category
Services
Procedure
Open procedure
Rules
Procurement Act 2023
SME suitable
Yes
Published
8 September 2025
Questions by
22 September 2025
Deadline
Closed
Classification (CPV)
Financial auditing servicesTax consultancy services

Award outcome

Award date
21 November 2025
Contract period
27 November 2025 → 28 November 2028
Contract length
3 years
Bids received
9
Winner
  • Ernst & Young LLC

This contract ends on 28 November 2028.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

About the winner

Ernst & Young LLC

Based in
Kyiv
Public contracts won
2
Across UK and EU notices

No other contract from CELL THERAPY CATAPULT LIMITED under this supplier name in Skim's records.

See every contract Ernst & Young LLC holds and when each one ends

Competition and scoring

Bids received

9

1 from SMEs

Open and restricted tenders in Business services: law, marketing, consulting, recruitment, printing and security drew a median of 4 bids over the last 24 months; 21% received only one.

How bids were scored

Price 40% · Quality 60%

  • Previous Experience and Contract Examples10%
  • Understanding of brief and Delivery Plan15%
  • Communication and responses10%
  • Strength of Audit Team15%
  • Presentation10%
  • Price40%

Price and cost criteria in black, quality in blue.

Market context

Typical award in Business services: law, marketing, consulting, recruitment, printing and security

£73,982

Median of 18,935 awards in the last 24 months

CELL THERAPY CATAPULT LIMITED in the last 12 months

31

contracts awarded, worth £1,596,655 in total

See their procurement profile →

Recent awards in Business services: law, marketing, consulting, recruitment, printing and security

The latest contracts other buyers awarded under the same classification.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    21 November 2025

  2. Contract Notice

    8 September 2025

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.